Stanford School of Medicine
General Clinical
Research Center

Richard B. Moss

Profile: http://med.stanford.edu/profiles/Richard_Moss/

Contact:
Name: Eleilda Ayala
Title: Administrative Associate
Email: eleildaa@stanford.edu
Phone: 650-723-5191

Academic Appointments
Appointment
Organization
Professor - Med Center Line
Graduate & Fellowship Program Affiliations
 
Honors & Awards
Title
Organization
Date(s)
Best Doctors in America
Best Doctors
2001-2005
America's Top Pediatricians-Pulmonology
Consumers Research Council of America
2002-2006
Professional of the Year
Cystic Fibrosis Research, Inc.
2003
Member
American Pediatric Society
2005
Who's Who in America
Marquis
2006
Administrative Appointments
Title
Organization
Start Year
End Year
Chief, Allergy-Immunology
Pediatrics, Stanford University
2005
-
Chief, Allergy-Immunology
Pediatrics, Stanford University
1991
1996
Chief, Pediatric Pulmonology
Stanford University
1991
2006
Director, Cystic Fibrosis Center
Stanford University
1991
-
Principal Investigator, CF Therapeutics Development Network Center
Stanford University
1999
-
8  appointments: view full list
Professional Education
Degree
Awarding Institution
Field of Study
Year of Graduation
BA
Columbia University
Political Science
1971
MD
SUNY Downstate Med Center NYC
Medicine
1975
Web Site Links
Research/Lab website:   Stanford Cystic Fibrosis Center
Research Interests

I am interested in the immunopathogenesis of chronic airways diseases of childhood. My work includes basic and clinical research. In the area of basic research, my laboratory has focused on immunoregulation of inflammation in cystic fibrosis, finding deficiencies of activated T cells from CF patients in production of counter-regulatory cytokines (IL-10, IFN-gamma) and redox metabolism. In the arena of clinical research, as a member of the CFF Therapeutics Development Network our research group conducts many trials. I have a particular interest in the field of aerosol gene therapy for in vivo correction of genetic lung disease, focusing on AAV-CFTR transfer for CF. We are also investigating new treatments for CF complications such as diabetes and osteoporosis, internet-based disease management, and trials of asthma drugs.

Community and International Work
Publications
  • Robinson TE, Emond MJ, Chen X, Moss RB "Chest HRCT discriminates bacterial infection effects on disease severity in children with mild cystic fibrosis." Submitted. More »
  • Moss RB, "Antibiotic treatment of cystic fibrosis: new pulmonary guidelines expose a gap between actual and 'ideal' treatment" Submitted More »
  • Tirouvanziam R, Gernez Y, Conrad CK, Moss RB, Schrijver I, Dunn CE, Davies ZA, Herzenberg LA, Herzenberg LA "Profound functional and signalling changes in viable neutrophils homing to cystic fibrosis airways" Proceed Natl Acad Sci USA 2008; 105: 4335-4339 More »
  • Moss RB, "Allergic bronchopulmonary aspergillosis" In Latge JP, Steinbach WJ, Eds. Aspergillus Fumigatus and Aspergillosis. ASM Press 2008; In press More »
  • Moss RB, "Management of allergic aspergillosis" Current Fungal Infection Reports 2008; 2: 87-93 More »
158 publications:   view full list

Institution Links:

Footer Links: